Pharmaceutical Technology

JUNE 24, 2025

This rapid processing not only enhances throughput, but will also allow pharmaceutical companies to respond more swiftly to market demands. DMC’s innovative design incorporates an ultrathin conductive layer, typically made of gold, which enables the application of electrical fields across ionic and affinity membrane adsorbers.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Packaging Biosimilars Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 19, 2025

Both modalities have emerged as the most used platform technologies in developing oligonucleotide-based drugs for CNS disorders since 2020. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51 billion) of these deals.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

DECEMBER 9, 2022

Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. Brazilian public spending on healthcare, drug pricing reforms and remote medicine. . <p>Early

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

Pharmaceutical Technology

JUNE 25, 2025

By GlobalData Learn more about Strategic Intelligence In light of the approvals of Leqembi and Kisunla, large pharmaceutical companies are increasingly investing in Alzheimer’s disease through high-value acquisitions. Stay proactive with real-time data and expert analysis.

Packaging 59

Packaging Biosimilars Communication Hospitals 59

Pharmaceutical Technology

JUNE 25, 2025

Other countries from outside the EU and international organisations such as pharmaceutical companies will be able to apply to join HealthData@EU for secondary use in March 2034. In March 2031, secondary use data will be made available, including medical images, lab results, and hospital discharge reports.

Communication 52

Communication Hospitals Packaging Pharmaceutical Companies 52

European Pharmaceutical Review

DECEMBER 21, 2022

“As the contribution of costs of organic chemicals used as feedstock to the operating expenditures is small, the pharmaceutical companies can spearhead and guide the transition.” He is currently group leader of the Technology Development and Discovery Group at the Bioprocess Laboratory of the ETH. 199‒208.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

FEBRUARY 28, 2023

For many years, the pharmaceutical industry has been accused of overlooking this patient population by instead targeting investments toward more prevalent indications. Orphan drug development is expanding Change is happening. With similar incentives offered by EU/EEA and UK law, orphan drug development has taken off.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Communication 52

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. This was higher than the number of approvals in 2019 and 2020. Regulators are also paying close attention to the risks.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Putting Patients First Blog

JUNE 30, 2023

No mention was provided in the proposed changes nor the white paper on Advancing Health Technology Assessment Methods that Support Health Equity of clinical trial participants with differential abilities. have robust suggestions on increasing diversity in clinical trials for sponsors and drug developers.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Drug Development 40

Pharmaceutical Technology

FEBRUARY 20, 2023

We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ)

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52

Pharmaceutical Technology

JUNE 25, 2025

Vaccine R&D stagnation likely Although ACIP recommendations are separate from the US Food and Drug Administration (FDA)’s approvals, national immunisation recommendation provides a key pillar on which to guide pipeline development for a pharmaceutical company.

Vaccines 115

Vaccines Hospitals Packaging Communication 115

Pharmaceutical Technology

JUNE 27, 2025

It feels like in the US, pharmaceutical companies are capitalising on people’s frustration and desperation to lose weight.” Unintended compounded price point Compounded drugs are custom-made and unbranded medications that contain the same active ingredient as a marketed drug, such as semaglutide or tirzepatide via a prescription.

59

59